GARENOXACIN PROPHYLAXIS FOR FEBRILE NEUTROPENIA AFTER CHEMOTHERAPY IN HEMATOLOGICAL MALIGNANCIES

被引：0
|
作者：
Nakamura, N. [1 ]
Tsurumi, H. [1 ]
Shibata, Y. [1 ]
Mabuchi, R. [1 ]
Kitagawa, J. [1 ]
Suetsugu, A. [1 ]
Kanemura, N. [1 ]
Goto, N. [1 ]
Hara, T. [1 ]
Moriwaki, H. [1 ]
机构：
[1] Gifu Univ, Dept Internal Med 1, Grad Sch Med, Gifu, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：47 / 47
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
    Alvarez, Jose C.
    Cuervo, Sonia I.
    Silva, Edelberto
    Diaz, Jorge A.
    Jimenez, Lorena L.
    Parra, Daniel S.
    Gomez, Julio C.
    Sanchez, Ricardo
    Cortes, Jorge A.
    ANTIBIOTICS-BASEL, 2021, 10 (05):
  • [2] Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
    José C Álvarez
    Sonia I Cuervo
    Javier R Garzón
    Julio C Gómez
    Jorge Augusto Díaz
    Edelberto Silva
    Ricardo Sánchez
    Jorge A Cortés
    BMC Pharmacology and Toxicology, 14
  • [3] Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
    Alvarez, Jose C.
    Cuervo, Sonia I.
    Garzon, Javier R.
    Gomez, Julio C.
    Diaz, Jorge Augusto
    Silva, Edelberto
    Sanchez, Ricardo
    Cortes, Jorge A.
    BMC PHARMACOLOGY & TOXICOLOGY, 2013, 14 : 59
  • [4] A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies
    Moreau, M.
    Klastersky, J.
    Schwarzbold, A.
    Muanza, F.
    Georgala, A.
    Aoun, M.
    Loizidou, A.
    Barette, M.
    Costantini, S.
    Delmelle, M.
    Dubreucq, L.
    Vekemans, M.
    Ferrant, A.
    Bron, D.
    Paesmans, M.
    ANNALS OF ONCOLOGY, 2009, 20 (03) : 513 - 519
  • [5] Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study
    Ludwig, Heinz
    Bokemeyer, Carsten
    Aapro, Matti
    Boccadoro, Mario
    Gascon, Pere
    Denhaerynck, Kris
    Krendyukov, Andriy
    Abraham, Ivo
    MacDonald, Karen
    FUTURE ONCOLOGY, 2019, 15 (08) : 897 - 908
  • [6] G-CSF prophylaxis of febrile neutropenia and infections after chemotherapy
    Link, H.
    ONKOLOGE, 2014, 20 (03): : 268 - 270
  • [7] Efficacy and safety of micafungin for treating febrile neutropenia in hematological malignancies
    Goto, Naoe
    Hara, Takeshi
    Tsurumi, Hisashi
    Ogawa, Kengo
    Kitagawa, Junichi
    Kanemura, Nobuhiro
    Kasahara, Senji
    Yamada, Toshiki
    Shimizu, Masahito
    Nakamura, Mitsuhiro
    Matsuura, Katsuhiko
    Moriwaki, Hisataka
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (11) : 872 - 876
  • [8] Mortality in patients with hematological malignancies, febrile neutropenia, and septic shock
    Islas-Munoz, Beda
    Volkow-Fernandez, Patricia
    Silva-Zamora, Jorge
    Ramirez-Ibarguen, Ana
    Cornejo-Juarez, Patricia
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (02): : 235 - 242
  • [9] FEBRILE NEUTROPENIA AND AVAILABLE BIOMARKERS AMONG CHILDREN WITH HEMATOLOGICAL MALIGNANCIES
    Garcia-Espinoza, A.
    Figueroa-Carbajal, J.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 234 - 235
  • [10] FEBRILE NEUTROPENIA AND AVAILABLE BIOMARKERS AMONG CHILDREN WITH HEMATOLOGICAL MALIGNANCIES
    Kourti, M.
    Iosifidis, I.
    Slavakis, A.
    Geladari, A.
    Goumberi, S.
    Roilides, E.
    Koliouskas, D.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 234 - 234
12345